Home » Topics » Regulatory » Patents

Patents
RSS

Janssen R&D Ireland presents novel anti-influenza compounds

Aug. 7, 2017

Boehringer Ingelheim patents nuclear receptor RORgamma antagonists

Aug. 7, 2017

Ningbo Wenda describes novel bromodomain-containing protein 4 inhibitors

Aug. 7, 2017

Sichuan Haisco Pharmaceutical divulges new antivirals

Aug. 4, 2017

Janssen Pharmaceutica identifies MAP3K14 inhibitors

Aug. 4, 2017

Beth Israel Deaconess Medical Center discloses CRAC blockers

Aug. 4, 2017

U.S. researchers patent antiparasitic compounds

Aug. 4, 2017

Boehringer Ingelheim discloses BTK and IL-6 production inhibitors

Aug. 3, 2017

RSV inhibitors identified by Enanta Pharmaceuticals

Aug. 3, 2017

Bristol-Myers Squibb presents ROCK2 inhibitors

Aug. 3, 2017

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...